DelMar Pharmaceuticals Announces Fiscal Year 2019 Financial Results and Recent Corporate Updates
Advertisement
Company Estimates Cash Runway Sufficient to Report Top-Line Results from Two of Three Patient Groups in Phase 2 Trials By 4th Quarter of Calendar Year 2020